Bexa Breast Exam for Breast Cancer Detection
(BBE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Bexa Breast Exam treatment for breast cancer detection?
Research on breast self-examination (BSE), a similar method, shows that it can help detect breast cancer earlier by identifying smaller tumors and improving survival rates, especially in post-menopausal women. While BSE is not as sensitive as mammograms, it is a useful additional tool for early detection.12345
How is the Bexa Breast Exam treatment different from other breast cancer detection methods?
The Bexa Breast Exam is unique because it focuses on a specific examination technique for early breast cancer detection, unlike mammography which may not be accessible to all women. It emphasizes self-examination, which is a self-care method that women can perform regularly to detect changes in their breasts.35678
What is the purpose of this trial?
Objective:The "Bexa Breast Exam," or "BBE," for the purposes of this study is defined as the use of a Bexa device in conjunction with a portable, focused ultrasound examination to identify and further evaluate abnormal breast masses including cancer. Commercially, this combination of Bexa plus focused ultrasound is called "Bexa Breast ExamTM," and abbreviated as, "BBE." This study compares the Bexa Breast Exam (BBE) to the standard of care (digital breast tomosynthesis) in detecting masses and as a breast cancer early detection examination.The specific objectives are:1. To measure the sensitivity and specificity of BBE as compared to digital breast tomosynthesis in the general population of women over 30 without a history of breast cancer.2. To measure the sensitivity and specificity of BBE as compared to digital breast tomosynthesis identifying breast masses including cancer in women with dense breasts.3. To demonstrate the proportion of women receiving a BBE that require additional imaging studies.Hypothesis:The purpose of this study is to demonstrate that the Bexa Breast Examination's sensitivity and specificity in identifying abnormal breast masses is comparable to the current accepted standard of care, mammography with tomosynthesis.
Research Team
John Cole, DO
Principal Investigator
Hendrick Health
Eligibility Criteria
This trial is for women over 30 without a history of breast cancer. It's specifically looking at those with dense breasts to see if the Bexa Breast Exam (BBE) can find abnormal masses as well as standard mammography with tomosynthesis does.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Procedure
Participants undergo the Bexa Breast Exam and digital breast tomosynthesis for mass detection
Follow-up
Participants are monitored for safety and effectiveness after the procedure
Treatment Details
Interventions
- Bexa Breast Exam
Bexa Breast Exam is already approved in United States for the following indications:
- Documentation of abnormal breast tissues and masses discovered during breast examination
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sure, Inc.
Lead Sponsor
Hendrick Medical Center
Collaborator